BNR · NASDAQ
Burning Rock Biotech (BNR) Stock Price & Fundamentals
Burning Rock Biotech (BNR) closed at $386.31 on Oct 9, 2026, up 1.14% from the previous close of $381.97.
Share price, past year
1Y +4.37%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $386.31 |
| Sep 30, 2026 | $384.43 |
| Aug 31, 2026 | $378.25 |
| Jul 31, 2026 | $386.32 |
| Jun 30, 2026 | $376.00 |
| May 29, 2026 | $369.50 |
| Apr 30, 2026 | $385.90 |
| Mar 31, 2026 | $407.94 |
| Feb 27, 2026 | $433.47 |
| Jan 30, 2026 | $439.33 |
| Dec 31, 2025 | $405.46 |
| Nov 28, 2025 | $404.35 |
| Oct 31, 2025 | $382.01 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 0
- Dividend yield
- —
- 52-week range
- $363.34 – $445.50
Financials
Burning Rock Biotech reported revenue of $77.16M for fiscal 2025, up 9.18% from fiscal 2024.
Burning Rock Biotech reported a net loss of $7.92M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $77.16M | +9.2% | −$7.92M | −10.3% | — | −$4.82M |
| FY2024ended Dec 31, 2024 | $70.67M | −6.6% | −$47.49M | −67.2% | — | −$13.38M |
| FY2023ended Dec 31, 2023 | $75.70M | −7.3% | −$92.07M | −121.6% | — | −$37.17M |
| FY2022ended Dec 31, 2022 | $81.66M | +2.5% | −$140.82M | −172.4% | — | −$75.23M |
| FY2021ended Dec 31, 2021 | $79.69M | +21.0% | −$125.02M | −156.9% | $0.00 | −$107.05M |
| FY2020ended Dec 31, 2020 | $65.89M | — | −$62.41M | −94.7% | $0.00 | −$20.51M |
Company profile
- Name
- Burning Rock Biotech Ltd
- Ticker
- BNR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Medical Laboratories
- Headquarters
- No. 5 Xingdao Ring Road North,, International Bio Island, Guangzhou, Guangdong, 510005
- SEC CIK
- 0001792267
Frequently asked questions
What is Burning Rock Biotech's stock price?
Burning Rock Biotech (BNR) closed at $386.31 on Oct 9, 2026, up 1.14% from the previous close of $381.97.
How much revenue does Burning Rock Biotech make?
Burning Rock Biotech reported revenue of $77.16M for fiscal 2025, up 9.18% from fiscal 2024.
Sources and methodology
Fundamentals come from Burning Rock Biotech Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures